Angiotensin ii activates AMPK for execution of apoptosis through energy-dependent and -independent mechanisms

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 301, Issue 5, 2011, Pages

  Day, Regina M ^a   Lee, Young H ^a   Han, Li ^a   Kim, Yong Chul ^a   Feng, Ying Hong ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

AMP dependent kinase; Bcl x L; Endothelial cells; G protein coupled receptor; Src homology two domain containing phosphatase 2

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMINO ACID; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MESSENGER RNA; MUTANT PROTEIN; OLIGOMYCIN; PROTEIN BCL XL; PROTEIN TYROSINE PHOSPHATASE SHP 2;

ANIMAL CELL; APOPTOSIS; ARTERY ENDOTHELIUM; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL ENERGY; CHO CELL; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; FEMALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PULMONARY ARTERY; RNA STABILITY; WILD TYPE;

ADENOSINE TRIPHOSPHATE; AMP-ACTIVATED PROTEIN KINASES; ANGIOTENSIN II; ANIMALS; APOPTOSIS; BCL-X PROTEIN; BLOTTING, WESTERN; CATTLE; CRICETINAE; CRICETULUS; ENDOTHELIAL CELLS; ENZYME ACTIVATION; MUTATION; PLASMIDS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; PULMONARY ARTERY; RECEPTOR, ANGIOTENSIN, TYPE 2; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAINS; TRANSFECTION;

EID: 80055107376     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00072.2011     Document Type: Article

References (46)

1. Bedecs K, Elbaz N, Sutren M, Masson M, Susini C, Strosberg AD, Nahmias C. Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase. Biochem J 325: 449-454, 1997.
2. Chen MB, Shen WX, Yang Y, Wu XY, Gu JH, Lu PH. Activation of AMP-activated protein kinase is involved in vincristine-induced cell apoptosis in B16 melanoma cell. J Cell Physiol 226: 1915-1925, 2010.
3. Chen MB, Wu XY, Gu JH, Guo QT, Shen WX, Lu PH. Activation of AMP-activated protein kinase contributes to doxorubicin-induced cell death and apoptosis in cultured myocardial H9c2 cells. Cell Biochem Biophys 60: 311-322, 2011.
4. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52: 415-472, 2000.
5. Feng YH, Miura S, Husain A, Karnik SS. Mechanism of constitutive activation of the AT1 receptor: influence of the size of the agonist switch binding residue Asn(111). Biochemistry 37: 15791-15798, 1998.
6. Feng YH, Saad Y, Karnik SS. Reversible inactivation of AT(2) angiotensin II receptor from cysteine-disulfide bond exchange. FEBS Lett 484: 133-138, 2000.
7. Feng YH, Sun Y, Douglas JG. Gbeta gamma -independent constitutive association of Galpha s with SHP-1 and angiotensin II receptor AT2 is essential in AT2-mediated ITIM-independent activation of SHP-1. Proc Natl Acad Sci USA 99: 12049-12054, 2002.
8. Feng YH, Zhou L, Sun Y, Douglas JG. Functional diversity of AT2 receptor orthologues in closely related species. Kidney Int 67: 1731-1738, 2005.
9. Hardie DG. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol 8: 774-785, 2007.
10. Hardie DG, Carling D, Carlson M. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu Rev Biochem 67: 821-855, 1998.
11. Higuchi S, Ohtsu H, Suzuki H, Shirai H, Frank GD, Eguchi S. Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology. Clin Sci (Lond) 112: 417-428, 2007.
12. Horiuchi M, Hayashida W, Kambe T, Yamada T, Dzau VJ. Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogenactivated protein kinase phosphatase-1 and induces apoptosis. J Biol Chem 272: 19022-19026, 1997.
13. Hutchinson DS, Summers RJ, Bengtsson T. Regulation of AMPactivated protein kinase activity by G-protein coupled receptors: potential utility in treatment of diabetes and heart disease. Pharmacol Ther 119: 291-310, 2008.
14. Kass GE, Eriksson JE, Weis M, Orrenius S, Chow SC. Chromatin condensation during apoptosis requires ATP. Biochem J 318: 749-752, 1996.
15. Kim YM, Hwang JT, Kwak DW, Lee YK, Park OJ. Involvement of AMPK signaling cascade in capsaicin-induced apoptosis of HT-29 colon cancer cells. Ann NY Acad Sci 1095: 496-503, 2007.
16. Kishi K, Yuasa T, Minami A, Yamada M, Hagi A, Hayashi H, Kemp BE, Witters LA, Ebina Y. AMP-Activated protein kinase is activated by the stimulations of G(q)-coupled receptors. Biochem Biophys Res Commun 276: 16-22, 2000.
17. Kitta K, Day RM, Ikeda T, Suzuki YJ. Hepatocyte growth factor protects cardiac myocytes against oxidative stress-induced apoptosis. Free Radic Biol Med 31: 902-910, 2001.
18. Krown KA, Page MT, Nguyen C, Zechner D, Gutierrez V, Comstock KL, Glembotski CG, Quintana PJE, Sabbadini RA. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes: involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest 98: 2854-2865, 1996.
19. Lee YH, Marquez AP, Mungunsukh O, Day RM. Hepatocyte growth factor inhibits apoptosis by the profibrotic factor angiotensin II via extracellular signal-regulated kinase 1/2 in endothelial cells and tissue explants. Mol Biol Cell 21: 4240-4250, 2010.
20. Lee YH, Mungunsukh O, Tutino RL, Day RM. Angiotensin II-induced apoptosis requires SHP-2 regulation of nucleolin and Bcl-xL in primary lung endothelial cells. J Cell Sci 123: 1634-1643, 2010.
21. Lee YK, Hwang JT, Kwon DY, Surh YJ, Park OJ. Induction of apoptosis by quercetin is mediated through AMPKalpha1/ASK1/p38 pathway. Cancer Lett 292: 228-236, 2010.
22. Lee YK, Park SY, Kim YM, Park OJ. Regulatory effect of the AMPKCOX- 2 signaling pathway in curcumin-induced apoptosis in HT-29 colon cancer cells. Ann NY Acad Sci 1171: 489-494, 2009.
23. Li J, Yan B, Huo Z, Liu Y, Xu J, Sun Y, Liang D, Peng L, Zhang Y, Zhou ZN, Shi J, Cui J, Chen YH. Beta2- but not beta1-adrenoceptor activation modulates intracellular oxygen availability. J Physiol 588: 2987-2998, 2010.
24. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86: 147-157, 1996.
25. Miura S, Karnik SS. Ligand-independent signals from angiotensin II type 2 receptor induce apoptosis. EMBO J 19: 4026-4035, 2000.
26. Miura S, Karnik SS, Saku K. Constitutively active homo-oligomeric angiotensin II type 2 receptor induces cell signaling independent of receptor conformation and ligand stimulation. J Biol Chem 280: 18237-18244, 2005.
27. Nagata D, Takeda R, Sata M, Satonaka H, Suzuki E, Nagano T, Hirata Y. AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation. Circulation 110: 444-451, 2004.
28. Nakatsu Y, Kotake Y, Hino A, Ohta S. Activation of AMP-activated protein kinase by tributyltin induces neuronal cell death. Toxicol Appl Pharmacol 230: 358-363, 2008.
29. Perez DM, Karnik SS. Multiple signaling states of G-protein-coupled receptors. Pharmacol Rev 57: 147-161, 2005.
30. Porrello ER, Delbridge LM, Thomas WG. The angiotensin II type 2 (AT2) receptor: an enigmatic seven transmembrane receptor. Front Biosci 14: 958-972, 2009.
31. Sanders MJ, Grondin PO, Hegarty BD, Snowden MA, Carling D. Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. Biochem J 403: 139-148, 2007.
32. Scott JW, Ross FA, Liu JK, Hardie DG. Regulation of AMP-activated protein kinase by a pseudosubstrate sequence on the gamma subunit. EMBO J 26: 806-815, 2007.
33. Singh S, Khar A. Differential gene expression during apoptosis induced by a serum factor: role of mitochondrial F0-F1 ATP synthase complex. Apoptosis 10: 1469-1482, 2005.
34. Steckelings UM, Kaschina E, Unger T. The AT2 receptor-a matter of love and hate. Peptides 26: 1401-1409, 2005.
35. Sun BK, Deaton AM, Lee JT. A transient heterochromatic state in Xist preempts X inactivation choice without RNA stabilization. Mol Cell 21: 617-628, 2006.
36. Towler MC, Hardie DG. AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res 100: 328-341, 2007.
37. Uhal BD, Gidea C, Bargout R, Bifero A, Ibarra-Sunga O, Papp M, Flynn K, Filippatos G. Captopril inhibits apoptosis in human lung epithelial cells: a potential antifibrotic mechanism. Am J Physiol Lung Cell Mol Physiol 275: L1013-L1017, 1998.
38. Viollet B, Athea Y, Mounier R, Guigas B, Zarrinpashneh E, Horman S, Lantier L, Hebrard S, Devin-Leclerc J, Beauloye C, Foretz M, Andreelli F, Ventura-Clapier R, Bertrand L. AMPK: Lessons from transgenic and knockout animals. Front Biosci 14: 19-44, 2009.
39. Wang R, Alam G, Zagariya A, Gidea C, Pinillos H, Lalude O, Choudhary G, Oezatalay D, Uhal BD. Apoptosis of lung epithelial cells in response to TNF-alpha requires angiotensin II generation de novo. J Cell Physiol 185: 253-259, 2000.
40. Wang R, Zagariya A, Ang E, Ibarra-Sunga O, Uhal BD. Fas-induced apoptosis of alveolar epithelial cells requires ANG II generation and receptor interaction. Am J Physiol Lung Cell Mol Physiol 277: L1245-L1250, 1999.
41. Witczak CA, Sharoff CG, Goodyear LJ. AMP-activated protein kinase in skeletal muscle: from structure and localization to its role as a master regulator of cellular metabolism. Cell Mol Life Sci 65: 3737-3755, 2008.
42. Wong KA, Lodish HF. A revised model for AMP-activated protein kinase structure: The alpha-subunit binds to both the beta- and gammasubunits although there is no direct binding between the beta- and gamma-subunits. J Biol Chem 281: 36434-36442, 2006.
43. Xoriuchi M, Hamai M, Cui TX, Iwai M, Minokoshi Y. Cross talk between angiotensin II type 1 and type 2 receptors: cellular mechanism of angiotensin type 2 receptor-mediated cell growth inhibition. Hypertens Res 22: 67-74, 1999.
44. Yamada T, Horiuchi M, Dzau VJ. Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci USA 93: 156-160, 1996.
45. Yang D, Yaguchi T, Nakano T, Nishizaki T. Adenosine Activates AMPK to phosphorylate Bcl-X(L) responsible for mitochondrial damage and DIABLO release in HuH-7 cells. Cell Physiol Biochem 27: 71-78, 2011.
46. Yasuhara N, Eguchi Y, Tachibana T, Imamoto N, Yoneda Y, Tsujimoto Y. Essential role of active nuclear transport in apoptosis. Genes Cells 2: 55-64, 1997.